HEMOLEVEN Trademark

Trademark Overview

On Friday, May 6, 2011, a trademark application was filed for HEMOLEVEN with the United States Patent and Trademark Office. The USPTO has given the HEMOLEVEN trademark a serial number of 79099670. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, October 18, 2023. This trademark is owned by LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES. The HEMOLEVEN trademark is filed in the Pharmaceutical Products and Paper & Printed Material Products categories with the following description:

Protein concentrates of human blood origin, for use in treating blood coagulation Factor XI deficiencies

Printed matter, namely, pamphlets, catalogs, newspapers, booklets, periodicals, books, reports on clinical studies, informational letters, and journals, all of the foregoing in the field of protein concentrates of human blood origin
hemoleven

General Information

Serial Number79099670
Word MarkHEMOLEVEN
Filing DateFriday, May 6, 2011
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, October 18, 2023
Registration Number4144800
Registration DateTuesday, May 22, 2012
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, March 6, 2012

Trademark Statements

Goods and ServicesProtein concentrates of human blood origin, for use in treating blood coagulation Factor XI deficiencies
Goods and ServicesPrinted matter, namely, pamphlets, catalogs, newspapers, booklets, periodicals, books, reports on clinical studies, informational letters, and journals, all of the foregoing in the field of protein concentrates of human blood origin
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 28, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class016 - Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); printers' type; printing blocks.
US Class Codes002, 005, 022, 023, 029, 037, 038, 050
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 28, 2018
Primary Code016
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressF-91940 Les Ulis
FR
Party NameLABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR
Party NameLABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events

Event DateEvent Description
Monday, August 29, 2011NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, July 22, 2011SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Thursday, July 28, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 2, 2011APPLICATION FILING RECEIPT MAILED
Sunday, August 21, 2011ASSIGNED TO EXAMINER
Friday, August 26, 2011NON-FINAL ACTION WRITTEN
Saturday, August 27, 2011NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, August 29, 2011REFUSAL PROCESSED BY MPU
Monday, January 30, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, September 17, 2011REFUSAL PROCESSED BY IB
Tuesday, January 10, 2012TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 10, 2012ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 12, 2012EXAMINERS AMENDMENT -WRITTEN
Thursday, January 12, 2012EXAMINERS AMENDMENT E-MAILED
Thursday, January 12, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, January 12, 2012EXAMINER'S AMENDMENT ENTERED
Thursday, January 12, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 30, 2012ASSIGNED TO LIE
Saturday, November 24, 2012NOTIFICATION PROCESSED BY IB
Wednesday, February 15, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 15, 2012NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 15, 2012NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, March 6, 2012PUBLISHED FOR OPPOSITION
Tuesday, March 6, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 22, 2012REGISTERED-PRINCIPAL REGISTER
Wednesday, August 22, 2012FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, October 3, 2012FINAL DISPOSITION PROCESSED
Wednesday, October 3, 2012FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, September 10, 2019GENERIC MADRID TRANSACTION SENT TO IB
Sunday, March 3, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, November 11, 2013INTERNATIONAL REGISTRATION RENEWED
Monday, July 21, 2014NEW REPRESENTATIVE AT IB RECEIVED
Thursday, March 26, 2015NEW REPRESENTATIVE AT IB RECEIVED
Monday, May 22, 2017COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, December 28, 2018CANCELLED SECTION 71
Wednesday, August 28, 2019TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Tuesday, September 10, 2019GENERIC MADRID TRANSACTION CREATED
Friday, October 4, 2019TOTAL INVALIDATION PROCESSED BY THE IB
Monday, May 6, 2024DEATH OF INTERNATIONAL REGISTRATION
Monday, May 6, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Monday, May 6, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Thursday, April 15, 2021CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Friday, March 5, 2021NEW REPRESENTATIVE AT IB RECEIVED
Saturday, April 3, 2021CORRECTION TRANSACTION RECEIVED FROM IB
Friday, April 9, 2021NEW REPRESENTATIVE AT IB RECEIVED

Related Keywords

hemoleven blood protein origin concentrates human clinical books studies reports journals